Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo

被引:164
作者
Clayburgh, Daniel R.
Musch, Mark W.
Leitges, Michael
Fu, Yang-Xin
Turner, Jerrold R.
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[3] Hannover Med Sch, Dept Nephrol, D-3000 Hannover, Germany
关键词
D O I
10.1172/JCI29218
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Acute T cell-mediated diarrhea is associated with increased mucosal expression of proinflammatory cytokines, including the TNF superfamily members TNF and LIGHT. While we have previously shown that epithelial barrier dysfunction induced by myosin light chain kinase (MLCK) is required for the development of diarrhea, MLCK inhibition does not completely restore water absorption. In contrast, although TNF-neutralizing antibodies completely restore water absorption after systemic T cell activation, barrier function is only partially corrected. This suggests that, while barrier dysfunction is critical, other processes must be involved in T cell-mediated diarrhea. To define these processes in vivo, we asked whether individual cytokines might regulate different events in T cell-mediated diarrhea. Both TNF and LIGHT caused MLCK-dependent barrier dysfunction. However, while TNF caused diarrhea, LIGHT enhanced intestinal water absorption. Moreover, TNF, but not LIGHT, inhibited Na+ absorption due to TNF-induced internalization of the brush border Na+/H+ exchanger NHE3. LIGHT did not cause NHE3 internalization. PKC alpha activation by TNF was responsible for NHE3 internalization, and pharmacological or genetic PKC alpha inhibition prevented NHE3 internalization, Na+ malabsorption, and diarrhea despite continued barrier dysfunction. These data demonstrate the necessity of coordinated Na+ malabsorption and barrier dysfunction in TNF-induced diarrhea and provide insight into mechanisms of intestinal water transport.
引用
收藏
页码:2682 / 2694
页数:13
相关论文
共 61 条
  • [31] Na+-H+ exchanger 3 (NHE3) is present in lipid rafts in the rabbit ileal brush border:: a role for rafts in trafficking and rapid stimulation of NHE3
    Li, XH
    Galli, T
    Leu, S
    Wade, JB
    Weinman, EJ
    Leung, G
    Cheong, A
    Louvard, D
    Donowitz, M
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2001, 537 (02): : 537 - 552
  • [32] Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion
    Ma, TH
    Thiagarajah, JR
    Yang, H
    Sonawane, ND
    Folli, C
    Galietta, LJV
    Verkman, AS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) : 1651 - 1658
  • [33] INTERFERON-GAMMA DIRECTLY AFFECTS BARRIER FUNCTION OF CULTURED INTESTINAL EPITHELIAL MONOLAYERS
    MADARA, JL
    STAFFORD, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (02) : 724 - 727
  • [34] MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194
  • [35] MODIFICATION OF THE ANTI-CD3-INDUCED CYTOKINE RELEASE SYNDROME BY ANTI-INTERFERON-GAMMA OR ANTI-INTERLEUKIN-6 ANTIBODY TREATMENT - PROTECTIVE EFFECTS AND BIPHASIC CHANGES IN BLOOD CYTOKINE LEVELS
    MATTHYS, P
    DILLEN, C
    PROOST, P
    HEREMANS, H
    VANDAMME, J
    BILLIAU, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) : 2209 - 2216
  • [36] Regulation of apical membrane Na+/H+ exchangers NHE2 and NHE3 in intestinal epithelial cell line C2/bbe
    McSwine, RL
    Musch, MW
    Bookstein, C
    Xie, Y
    Rao, M
    Chang, EB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (03): : C693 - C701
  • [37] The human Na+-glucose cotransporter is a molecular water pump
    Meinild, AK
    Klaerke, DA
    Loo, DDF
    Wright, EM
    Zeuthen, T
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1998, 508 (01): : 15 - 21
  • [38] MULLIN JM, 1990, CANCER RES, V50, P2172
  • [39] T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase
    Musch, MW
    Clarke, LL
    Mamah, D
    Gawenis, LR
    Zhang, Z
    Alnadjim, Z
    Hurst, SD
    Chang, EB
    Barrett, TA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) : 1739 - 1747
  • [40] A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase
    Owens, SE
    Graham, WV
    Siccardi, D
    Turner, JR
    Mrsny, RJ
    [J]. PHARMACEUTICAL RESEARCH, 2005, 22 (05) : 703 - 709